Company profile

Idorsia

More news about Idorsia

20.03.2024 12:20

FDA approvals and encouraging results for innovative therapies
  • Success
    Please login or
    register to use the
    awards follow feature
    05.03.2024 17:00

    Business wind down and take off for listed Swiss startups
  • Financing
  • Setback
  • Success
    Please login or
    register to use the
    awards follow feature
    20.07.2023 08:58

    Idorsia sells its Asia Pacific operations to Sosei Heptares for CHF 400 million
  • Financing
    Please login or
    register to use the
    awards follow feature
    20.06.2023 16:40

    Fresh money for Santhera and Idorsia
  • Financing
    Please login or
    register to use the
    awards follow feature
    15.11.2022 16:31

    Idorsia’s insomnia drug available in first European countries
  • Expansion
  • Launch
    Please login or
    register to use the
    awards follow feature
    10.01.2022 11:40

    FDA approves Idorsia’s insomnia drug
  • Success
    Please login or
    register to use the
    awards follow feature
    22.10.2020 09:53

    Idorsia completes capital increase of CHF 535.5 million
  • Financing
    Please login or
    register to use the
    awards follow feature
    20.05.2020 16:38

    Idorsia raises CHF 330 million in new share offering
  • Financing
    Please login or
    register to use the
    awards follow feature
    20.04.2020 17:37

    Idorsia announces positive Phase 3 results for its lead product
  • Success
    Please login or
    register to use the
    awards follow feature
    21.12.2017 11:53

    Idorsia geht Forschungskooperation mit Roche ein
  • Success
    Please login or
    register to use the
    awards follow feature
    04.12.2017 14:00

    Idorsia collaborates with Janssen Biotech on aprocitentan

  • Background
  • Support
    Please login or
    register to use the
    awards follow feature
    Idorsia

    Founded
    2017

    Kanton
    Basel-Landschaft

    Homepage

    rss